Francisco Noya, MD
Axe de recherche primaire:
Santé respiratoire
Axe de recherche secondaire:
Infection et immunité
Courriel:
Courriel Le but de la recherche:
Traitement pharmacologique de l’asthme de l’enfant d’origine virale, interventions pluridimensionnelles de santé publique en vue de réduire la morbidité reliée à l’asthme, essais de vaccins et infections néonatales.Asthme, vaccins, essais cliniques, infections de l’enfant, phagocytose, immunoglobuline
Mots-clés:
Asthme, vaccins, essais cliniques, infections de l’enfant, phagocytose, immunoglobuline
Emplacement:
Montreal Children's Hospital Publications:
Halperin SA, McNeil S, Langley J, Blatter M, Dionne M, Embree J, Johnson R, Latiolais T, Meekison W, Noya F, Senders S, Zickler P, Johnson DR. Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous dose. Vaccine Jul 29. [Epub ahead of print]; 2011
Ducharme FM, Zemek RL, Chalut D, McGillivray D, Noya FJD, Resendes S, Khomenko L, Rouleau R, Zhang X. Written action plan in pediatric emergency room improves asthma prescribing, adherence, and control. Am J Respir Crit Care Med; 183:195-203; 2011
d'Hennezel E, Ben-Shoshan M, Ochs HD, Torgerson TR, Russell LJ, Lejtenyi C, Noya FJ, Jabado N, Mazer B, Piccirillo CA. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N Eng J Med; 361:1710-1713; 2009
Ducharme FM, Lemire C, Noya FJ, Davis GM, Alos N, Leblond H, Savdie C, Collet JP, Khomenko L, Rivard G, and Platt RW. Pre-emptive high-dose fluticasone for viral-induced wheeze in young children. N Eng J Med; 360:339-353; 2009
Ducharme FM, Noya F, McGillivray D, Resendes S, Ducharme-Bénard S, Zemek R, Bhogal SK, Rouleau R. Two for one: a self-management plan coupled with a prescription sheet for children with asthma. Can Resp J (In press); 2008
McNeil SA, Noya F, Dionne M, Predy G, Meekison W, Ojah C, Ferro S, Mills EL, Langley JM, Halperin SA. Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults. Vaccine 25: 3464-3474; 2007.
Barreto L, Guasparini R, Meekison W, Noya F, Young L, Mills E. Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine 25: 8172-8179; 2007.
